Tokyo Tape
Sign in
← Terumo

Half-year report · HY

4543.TEDINET S100X3VY
Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥534.9bn2025-04-01 → 2025-09-30Cons.Revenue IFRS
Revenue¥1.04T2024-04-01 → 2025-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥508.7bn2024-04-01 → 2024-09-30Cons.Revenue IFRS
Operating income¥101.0bn2025-04-01 → 2025-09-30Cons.Operating profit loss IFRS
Operating income¥87.7bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Profit before tax¥101.2bn2025-04-01 → 2025-09-30Cons.Profit loss before tax IFRS
Profit before tax¥154.6bn2024-04-01 → 2025-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥85.1bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Net income (owners)¥76.9bn2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥117.0bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥63.2bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥76.9bn2025-04-01 → 2025-09-30Cons.Profit loss IFRS
Net income¥63.2bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Total assets¥1.89Tat 2025-09-30Cons.Assets IFRS
Total assets¥1.83Tat 2025-03-31Cons.Assets IFRS
Total assets¥1.75Tat 2024-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥457.3bnat 2025-09-30Cons.Liabilities IFRS
Total liabilities¥459.9bnat 2025-03-31Cons.Liabilities IFRS
Net assets / equity¥1.44Tat 2025-09-30Cons.Equity IFRS
Net assets / equity¥1.37Tat 2025-03-31Cons.Equity IFRS
Net assets / equity¥1.31Tat 2024-09-30Cons.Equity IFRS
Net assets / equity¥1.33Tat 2024-03-31vCons.Equity IFRS
Equity (owners)¥1.44Tat 2025-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.37Tat 2025-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.31Tat 2024-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥217.2bnat 2025-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥221.9bnat 2025-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥194.9bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥204.9bnat 2024-03-31vCons.Cash and cash equivalents IFRS
Operating cash flow¥102.0bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥210.8bn2024-04-01 → 2025-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥100.9bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥71.0bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥82.5bn2024-04-01 → 2025-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥38.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥38.0bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥108.8bn2024-04-01 → 2025-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥65.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥52.132025-04-01 → 2025-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥79.012024-04-01 → 2025-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥42.572024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥52.122025-04-01 → 2025-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥78.992024-04-01 → 2025-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥42.562024-04-01 → 2024-09-30Cons.Diluted earnings loss per share IFRS
Equity ratio75.9%at 2025-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio74.8%at 2025-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio75.0%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue external2025-04-01 → 2025-09-30¥163m
Reconciling Itemsreconcilingsegment profit2025-04-01 → 2025-09-30−¥1.8bn
Blood And Cell Technologies Companyreportable segmentrevenue external2025-04-01 → 2025-09-30¥107.1bn
Blood And Cell Technologies Companyreportable segmentsegment profit2025-04-01 → 2025-09-30¥15.6bn
Cardiac And Vascular Companyreportable segmentrevenue external2025-04-01 → 2025-09-30¥322.1bn
Cardiac And Vascular Companyreportable segmentsegment profit2025-04-01 → 2025-09-30¥87.0bn
Medical Care Solutions Companyreportable segmentrevenue external2025-04-01 → 2025-09-30¥105.6bn
Medical Care Solutions Companyreportable segmentsegment profit2025-04-01 → 2025-09-30¥13.5bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥534.8bn
—segment totalsegment profit2025-04-01 → 2025-09-30¥116.2bn
Reconciling Itemsreconcilingrevenue external2024-04-01 → 2024-09-30¥132m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30¥1.2bn
Blood And Cell Technologies Companyreportable segmentrevenue external2024-04-01 → 2024-09-30¥98.0bn
Blood And Cell Technologies Companyreportable segmentsegment profit2024-04-01 → 2024-09-30¥13.2bn
Cardiac And Vascular Companyreportable segmentrevenue external2024-04-01 → 2024-09-30¥306.3bn
Cardiac And Vascular Companyreportable segmentsegment profit2024-04-01 → 2024-09-30¥76.9bn
Medical Care Solutions Companyreportable segmentrevenue external2024-04-01 → 2024-09-30¥104.3bn
Medical Care Solutions Companyreportable segmentsegment profit2024-04-01 → 2024-09-30¥12.7bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥508.6bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥102.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 630
ItemContextValueUnit
Share capital IFRSInterimInstant38716000000JPY
Capital surplus IFRSPrior1YearInstant51725000000JPY
Capital surplus IFRSInterimInstant51596000000JPY
Treasury shares IFRSPrior1YearInstant-14866000000JPY
Treasury shares IFRSInterimInstant-14546000000JPY
Retained earnings IFRSPrior1YearInstant1016160000000JPY
Retained earnings IFRSInterimInstant1073865000000JPY
Other components of equity IFRSPrior1YearInstant276800000000JPY
Other components of equity IFRSInterimInstant287904000000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant1368535000000JPY
Equity attributable to owners of parent IFRSInterimInstant1437536000000JPY
Equity IFRSPrior1YearInstant1368535000000JPY
Equity IFRSInterimInstant1437536000000JPY
Liabilities and equity IFRSPrior1YearInstant1828393000000JPY
Liabilities and equity IFRSInterimInstant1894821000000JPY
Revenue IFRSPrior1InterimDuration508685000000JPY
Revenue IFRSInterimDuration534930000000JPY
Cost of sales IFRSPrior1InterimDuration231663000000JPY
Cost of sales IFRSInterimDuration242466000000JPY
Gross profit IFRSPrior1InterimDuration277021000000JPY
Gross profit IFRSInterimDuration292464000000JPY
Selling general and administrative expenses IFRSPrior1InterimDuration184738000000JPY
Selling general and administrative expenses IFRSInterimDuration189862000000JPY
Other income IFRSPrior1InterimDuration3357000000JPY
Other income IFRSInterimDuration5196000000JPY
Other expenses IFRSPrior1InterimDuration7924000000JPY
Other expenses IFRSInterimDuration6813000000JPY
Operating profit loss IFRSPrior1InterimDuration87716000000JPY
Operating profit loss IFRSInterimDuration100983000000JPY
Finance income IFRSPrior1InterimDuration1758000000JPY
Finance income IFRSInterimDuration1896000000JPY
Finance costs IFRSPrior1InterimDuration4197000000JPY
Finance costs IFRSInterimDuration1296000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1InterimDuration-137000000JPY
Share of profit loss of investments accounted for using equity method IFRSInterimDuration-370000000JPY
Profit loss before tax IFRSPrior1InterimDuration85140000000JPY
Profit loss before tax IFRSInterimDuration101212000000JPY
Income tax expense IFRSPrior1InterimDuration21935000000JPY
Income tax expense IFRSInterimDuration24315000000JPY
Profit loss IFRSPrior1InterimDuration63204000000JPY
Profit loss IFRSInterimDuration76897000000JPY
Profit loss attributable to owners of parent IFRSPrior1InterimDuration63204000000JPY
Profit loss attributable to owners of parent IFRSInterimDuration76897000000JPY
Profit loss IFRSPrior1InterimDuration63204000000JPY
Profit loss IFRSInterimDuration76897000000JPY
Basic earnings loss per share IFRSPrior1InterimDuration42.57
Basic earnings loss per share IFRSInterimDuration52.13
Diluted earnings loss per share IFRSPrior1InterimDuration42.56
Diluted earnings loss per share IFRSInterimDuration52.12
Profit loss IFRSPrior1InterimDuration63204000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2025-03-31pass rounding
balance sheet identityconsolidated 2025-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass